43.03
price down icon0.69%   -0.30
after-market After Hours: 43.10 0.07 +0.16%
loading

Avidity Biosciences Inc Stock (RNA) Forecast

The Avidity Biosciences Inc (RNA) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $22.60, representing a -47.48% decrease from the current price of $43.03. The highest analyst price target is $25.98, and the lowest is $19.22.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RNA Price Target
Average 20.95 (-51.30% Downside)
loading

Is Avidity Biosciences Inc (RNA) A Buy Now?

Oscillators
Name Value Action
RSI(14) 45.42 Neutral
STOCH(9,6) 32.41 Neutral
STOCHRSI(14) 17.38 Buy
MACD(12,26) -0.6306 Sell
ADX(14) 8.7018 Neutral
William %R -78.61 Neutral
CCI(14) -52.07 Neutral
Buy: 1 Sell: 1 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
43.15
Sell
43.96
Sell
MA20
45.05
Sell
44.57
Sell
MA50
45.46
Sell
44.71
Sell
MA100
44.64
Sell
42.51
Buy
MA200
35.76
Buy
35.51
Buy
Buy: 3 Sell: 7 Neutral: 0
Summary: Sell
According to our latest analysis, RNA could be considered a Moderate Sell, with 17 technical analysis indicators signaling 4 Buy signals, 8 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on RNA, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 45.42 indicates that RNA is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 32.41 indicates that RNA is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 17.38 indicates that RNA is oversold. This suggests that RNA price is at or near the lowest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 8.7018 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -52.07 indicates that RNA is still oversold but not to an extreme extent.

Long-term RNA price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Avidity Biosciences Inc financial reports and earnings history, Avidity Biosciences Inc (RNA) stock could reach $18.99 by 2030, $11.76 by 2040 and $6.0876 by 2050. See the projected annual prices until 2050 of the Avidity Biosciences Inc stock below:

  • Avidity Biosciences Inc (RNA) is expected to reach an average price of $7.1556 in 2035, with a high prediction of $9.9122 and a low estimate of $5.6023. This indicates an $-83.37% rise from the last recorded price of $43.03.
  • Avidity Biosciences Inc (RNA) stock is projected to chart a bullish course in 2040, with an average price target of $11.71, representing an $-72.78% surge from its current level. The forecast ranges from a conservative $5.0182 to a sky-high $11.76.
  • Our analysts predict Avidity Biosciences Inc (RNA) to jump -76.53% by 2045, soaring from $8.8526 to an average price of $10.10, potentially reaching $13.02. While $8.8526 is the low estimate, the potential upside is significant.
  • Avidity Biosciences Inc (RNA) stock is expected to climb by 2050, reaching an average of $6.7176, a $-84.39% jump from its current level. However, a wide range of estimates exists, with high and low targets of $6.0876 and $5.7675, respectively, highlighting the market's uncertainty.

Avidity Biosciences Inc Stock (RNA) Year by Year Forecast

Avidity Biosciences Inc Stock (RNA) Price Forecast for 2025

Avidity Biosciences Inc Stock (RNA) is expected to reach an average price of $20.95 in 2025, with a high prediction of $26.96 and a low estimate of $14.95. This indicates an -51.30% fall from the last recorded price of $43.03.
Month Average Low High Change from today's price
January, 2025 $19.78 $19.22 $25.98 -54.03%
February, 2025 $20.31 $18.69 $25.02 -52.81%
March, 2025 $19.16 $17.17 $25.49 -55.47%
April, 2025 $20.80 $16.47 $23.25 -51.67%
May, 2025 $21.10 $16.86 $23.06 -50.96%
June, 2025 $26.63 $18.85 $26.73 -38.12%
July, 2025 $19.36 $18.51 $26.96 -55.01%
August, 2025 $17.53 $14.95 $19.43 -59.27%
September, 2025 $19.94 $15.48 $21.93 -53.66%
October, 2025 $20.38 $19.18 $22.36 -52.65%
November, 2025 $23.49 $17.67 $24.26 -45.41%
December, 2025 $20.60 $18.03 $26.64 -52.14%

Avidity Biosciences Inc Stock (RNA) Price Forecast for 2026

The predicted value for Avidity Biosciences Inc (RNA) in 2026 is set at an average of $16.36. Estimates vary from a peak of $24.40 to a trough of $8.3207, indicating an -61.98% surge from the present price of $43.03.
Month Average Low High Change from today's price
January, 2026 $21.17 $19.36 $24.40 -50.80%
February, 2026 $12.64 $10.79 $21.80 -70.62%
March, 2026 $12.34 $12.23 $15.10 -71.33%
April, 2026 $15.89 $12.07 $16.44 -63.06%
May, 2026 $17.16 $14.11 $18.75 -60.12%
June, 2026 $11.00 $10.77 $17.04 -74.43%
July, 2026 $10.54 $8.444 $12.55 -75.51%
August, 2026 $11.96 $8.3207 $13.22 -72.20%
September, 2026 $13.73 $11.93 $16.79 -68.10%
October, 2026 $19.38 $12.70 $21.01 -54.96%
November, 2026 $18.28 $15.90 $20.74 -57.52%
December, 2026 $11.68 $11.07 $18.84 -72.85%

Avidity Biosciences Inc Stock (RNA) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Avidity Biosciences Inc (RNA) is $14.13, with a high forecast of $23.21 and a low forecast of $5.0393. This indicates an -67.17% decrease from the last price of $43.03.
Month Average Low High Change from today's price
January, 2027 $12.30 $10.47 $14.31 -71.42%
February, 2027 $9.0917 $8.3517 $12.93 -78.87%
March, 2027 $17.30 $7.2928 $20.76 -59.80%
April, 2027 $21.17 $15.32 $21.59 -50.80%
May, 2027 $20.25 $19.65 $23.21 -52.95%
June, 2027 $17.51 $16.86 $22.86 -59.30%
July, 2027 $13.81 $10.62 $18.28 -67.92%
August, 2027 $8.3105 $7.8705 $15.04 -80.69%
September, 2027 $9.616 $7.8627 $10.21 -77.65%
October, 2027 $8.3304 $8.1393 $9.6171 -80.64%
November, 2027 $6.7849 $6.3626 $8.5815 -84.23%
December, 2027 $5.4704 $5.0393 $7.3438 -87.29%

Avidity Biosciences Inc Stock (RNA) Price Forecast for 2028

In 2028, Avidity Biosciences Inc (RNA) is projected to reach an average price of $15.97, with a high projection of $29.60 and a low estimate of $2.3454. This indicates an -62.87% fall from the last price of $43.03.
Month Average Low High Change from today's price
January, 2028 $3.8948 $3.6248 $5.4915 -90.95%
February, 2028 $2.3892 $2.3592 $4.4261 -94.45%
March, 2028 $3.7848 $2.3454 $4.2037 -91.20%
April, 2028 $6.1792 $3.4959 $6.2192 -85.64%
May, 2028 $7.6948 $5.9003 $9.4236 -82.12%
June, 2028 $10.89 $7.4659 $11.05 -74.69%
July, 2028 $17.65 $10.55 $17.89 -58.97%
August, 2028 $22.18 $13.84 $25.21 -48.46%
September, 2028 $21.68 $19.79 $23.57 -49.61%
October, 2028 $21.22 $20.10 $29.60 -50.68%
November, 2028 $18.35 $17.68 $23.61 -57.37%
December, 2028 $25.07 $18.02 $27.15 -41.73%

Avidity Biosciences Inc Stock (RNA) Price Forecast for 2029

The 2029 price forecast for Avidity Biosciences Inc Stock (RNA) is $22.96 on average, with a high prediction of $32.10 and a low estimate of $13.83. This represents an -46.64% decrease from the previous price of $43.03.
Month Average Low High Change from today's price
January, 2029 $28.95 $22.51 $32.10 -32.73%
February, 2029 $22.31 $20.89 $30.68 -48.14%
March, 2029 $22.63 $18.45 $25.25 -47.40%
April, 2029 $24.51 $22.46 $27.10 -43.04%
May, 2029 $20.10 $19.68 $30.69 -53.28%
June, 2029 $17.56 $17.01 $23.32 -59.19%
July, 2029 $18.82 $16.39 $22.37 -56.26%
August, 2029 $16.51 $14.52 $22.84 -61.63%
September, 2029 $17.19 $13.83 $20.49 -60.05%
October, 2029 $18.46 $14.22 $20.60 -57.10%
November, 2029 $23.99 $16.21 $24.09 -44.25%
December, 2029 $17.49 $15.88 $24.32 -59.36%

Avidity Biosciences Inc Stock (RNA) Price Forecast for 2030

Avidity Biosciences Inc Stock (RNA) is expected to reach an average price of $14.95 in 2030, with a high forecast of $24.03 and a low forecast of $5.868. This signifies an -65.25% decrease from the last price of $43.03.
Month Average Low High Change from today's price
January, 2030 $14.90 $12.33 $18.99 -65.37%
February, 2030 $17.32 $12.86 $19.31 -59.75%
March, 2030 $18.03 $16.56 $19.74 -58.10%
April, 2030 $17.25 $15.05 $19.21 -59.92%
May, 2030 $17.12 $15.68 $24.03 -60.22%
June, 2030 $20.41 $15.42 $21.79 -52.57%
July, 2030 $10.05 $8.1982 $20.73 -76.65%
August, 2030 $9.747 $9.637 $12.50 -77.35%
September, 2030 $12.36 $9.4792 $13.29 -71.29%
October, 2030 $14.58 $10.37 $16.17 -66.12%
November, 2030 $8.4258 $8.1958 $14.46 -80.42%
December, 2030 $8.7847 $5.868 $9.9703 -79.58%
$21.50
price up icon 1.61%
$74.59
price down icon 1.14%
$370.49
price down icon 2.02%
$43.06
price down icon 0.76%
$215.00
price up icon 4.29%
$118.39
price down icon 1.93%
Cap:     |  Volume (24h):